[
    [
        {
            "time": "2021-03-01",
            "original_text": "康龙化成（03759.HK）：君联闻达及君联茂林拟减持不超过5%公司股份 拟减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "君联闻达",
                    "君联茂林",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成（03759.HK）：君联闻达及君联茂林拟减持不超过5%公司股份 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "康龙化成（300759.SZ）：拟1.2亿美元收购生物制剂研发平台ABL全部股权",
            "features": {
                "keywords": [
                    "康龙化成",
                    "收购",
                    "生物制剂",
                    "ABL",
                    "股权"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成（300759.SZ）：拟1.2亿美元收购生物制剂研发平台ABL全部股权",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "港股异动|康龙化成(3759.HK)涨超6% 拟1.2亿美元收购生物制剂服务企业",
            "features": {
                "keywords": [
                    "康龙化成",
                    "港股",
                    "异动",
                    "收购",
                    "生物制剂"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动|康龙化成(3759.HK)涨超6% 拟1.2亿美元收购生物制剂服务企业",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "康龙化成拟1.2亿美元完控英国ABL公司",
            "features": {
                "keywords": [
                    "康龙化成",
                    "收购",
                    "英国",
                    "ABL",
                    "公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成拟1.2亿美元完控英国ABL公司",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "信义玻璃2020年度股东应占溢利同比增43.42%至64.22亿港元 末期股息每股62港仙",
            "features": {
                "keywords": [
                    "信义玻璃",
                    "股东应占溢利",
                    "同比增",
                    "股息"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "信义玻璃2020年度股东应占溢利同比增43.42%至64.22亿港元 末期股息每股62港仙",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]